These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 16400299)
1. Parkinson's disease: an enigma: highlights from the 8th International Congress of Parkinson's Disease and Movement Disorders, June 13-17, 2004, Rome, Italy. Weiner WJ Rev Neurol Dis; 2005; 2(1):20-2. PubMed ID: 16400299 [No Abstract] [Full Text] [Related]
3. Old and new dopamine agonists in Parkinson's disease. Proceedings of an international congress. Pisa, Italy, December 1993. J Neural Transm Suppl; 1995; 45():1-321. PubMed ID: 8847537 [No Abstract] [Full Text] [Related]
4. Insidious dopamine: provocateur or protective agent in Parkinson's disease? Kostrzewa RM; Brus R; Kostrzewa JP Pol J Pharmacol; 2001; 53(2):165-6. PubMed ID: 11787956 [No Abstract] [Full Text] [Related]
5. The Movement Disorder Society--14th International Congress of Parkinson's Disease and Movement Disorders. Grosset D; Grosset A IDrugs; 2010 Aug; 13(8):539-42. PubMed ID: 20721824 [TBL] [Abstract][Full Text] [Related]
6. GSK's Requip slow the loss of dopamine function in Parkinson's disease. Aviat Space Environ Med; 2002 Jul; 73(7):733. PubMed ID: 12137117 [No Abstract] [Full Text] [Related]
8. [Parkinson's disease]. de Saxce H Rev Infirm; 1979 Jan; 29(1):50-7. PubMed ID: 252780 [No Abstract] [Full Text] [Related]
9. Dysfunction of dopamine homeostasis: clues in the hunt for novel Parkinson's disease therapies. Bisaglia M; Greggio E; Beltramini M; Bubacco L FASEB J; 2013 Jun; 27(6):2101-10. PubMed ID: 23463698 [TBL] [Abstract][Full Text] [Related]
10. Placebo effect and dopamine release. de la Fuente-Fernández R; Lidstone S; Stoessl AJ J Neural Transm Suppl; 2006; (70):415-8. PubMed ID: 17017561 [TBL] [Abstract][Full Text] [Related]
11. Drugs of abuse and Parkinson's disease. Mursaleen LR; Stamford JA Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():209-17. PubMed ID: 25816790 [TBL] [Abstract][Full Text] [Related]
12. Medications for Parkinson's disease. Whitney CM Neurologist; 2007 Nov; 13(6):387-8. PubMed ID: 18090719 [No Abstract] [Full Text] [Related]
13. [Updates in practical neurology--I. The principles of modern levodopa therapy in Parkinson's disease]. Klivényi P; Vécsei L Ideggyogy Sz; 2007 Jan; 60(1-2):61-4. PubMed ID: 17432097 [TBL] [Abstract][Full Text] [Related]
15. Abstracts of the 8th International Congress of Parkinson's Disease and Movement Disorders. June 14-17, 2004. Rome, Italy. Mov Disord; 2004; 19 Suppl 9():S1-S491. PubMed ID: 15148659 [No Abstract] [Full Text] [Related]
16. [Drug-induced Parkinson's syndrome]. Degkwitz R Dtsch Med Wochenschr; 1972 Jun; 97(22):882. PubMed ID: 5032182 [No Abstract] [Full Text] [Related]
17. Treatment options for early Parkinson's disease. Stacy M; Brownlee HJ Am Fam Physician; 1996 Mar; 53(4):1281-7. PubMed ID: 8629572 [TBL] [Abstract][Full Text] [Related]
18. Clinical practice. Diagnosis and initial management of Parkinson's disease. Nutt JG; Wooten GF N Engl J Med; 2005 Sep; 353(10):1021-7. PubMed ID: 16148287 [No Abstract] [Full Text] [Related]
19. [Problems and future perspectives in the treatment of Parkinson's disease]. Hens L; Hellemans J Tijdschr Gerontol Geriatr; 1982 Aug; 13(4):147-54. PubMed ID: 6127822 [TBL] [Abstract][Full Text] [Related]
20. Treatment of Parkinson's disease. Calne DB N Engl J Med; 1993 Sep; 329(14):1021-7. PubMed ID: 8366903 [No Abstract] [Full Text] [Related] [Next] [New Search]